Literature DB >> 18492946

Lipopolysaccharide induces macrophage migration via prostaglandin D(2) and prostaglandin E(2).

Tsuyoshi Tajima1, Takahisa Murata, Kosuke Aritake, Yoshihiro Urade, Hiroyuki Hirai, Masataka Nakamura, Hiroshi Ozaki, Masatoshi Hori.   

Abstract

Lipopolysaccharide (LPS) produces prostaglandins (PGs) concomitant to eliciting macrophage migration. We evaluated the role of PGs in initiating the migration of macrophages, especially focusing on PGD(2) and PGE(2). In RAW264.7 macrophages, cyclooxygenase (COX)-2 inhibitor, CAY10404 [3-(4-methylsulphonylphenyl)-4-phenyl-5-trifluoromethylisoxazole], completely inhibited LPS-mediated migration at 4 h (early phase) but only partially inhibited the migration at 8 h (late phase), suggesting the presence of PG-dependent and -independent pathways. In the early phase, LPS up-regulated mRNA expressions of COX-2, hematopoietic PGD synthase (H-PGDS), and microsomal-PGE synthase 1, increasing PGD(2) and PGE(2) substantially. The chemoattractant receptor-homologous molecule expressed on Th2 lymphocytes (CRTH2) agonist, DK-PGD(2) (13-14-dihydro-15-keto-PGD(2)), and the EP4 agonist, ONO-AE1-329 (16-{3-methoxymethyl}phenyl-omega-tetranor-3,7-dithia-prostaglandin E(1)), but not selective agonists of D prostanoid receptor, E prostanoid receptor (EP) 2, or EP3, stimulated random migration (chemokinesis). In peritoneal macrophages from CRTH2-deficient and H-PGDS-deficient mice, LPS-mediated migration was significantly inhibited at either early or late phases of the migration. The H-PGDS inhibitor, HQL-79 [4-(diphenylmethoxy)-1-[3-(1H-tetrazol-5-yl)propyl-piperidine]], partially inhibited the migration of the RAW264.7 macrophage in both phases. These results suggest the importance of the PGD(2)/CRTH2 pathway in LPS-mediated migration of macrophages. In the late phase of migration, LPS up-regulated monocyte chemoattractant protein (MCP)-1 mRNA. The CC chemokine receptor (CCR2) antagonist, RS102895 [1'-[2-[4-(trifluoromethyl)phenyl]ethyl]-spiro[4H-3,1-benzoxazine-4,4'-piperidin]-2(1H)-one], inhibited LPS-mediated migration in the late phase without affecting the early phase. ONO-AE1-329, but not DK-PGD(2), up-regulated MCP-1 mRNA. Taken together, LPS stimulation of chemokinesis or chemotaxis, or both, occurs in macrophages via PGD(2) and PGE(2) in tandem arrangement; i.e., 1) LPS stimulates prostaglandin signaling, initiating early migration through the PGD(2)/CRTH2 and PGE(2)/EP4 signaling pathways; and 2) LPS leads induction of MCP-1, which contributes to later phase migration of the macrophages through the PGE(2)/EP4 pathway.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18492946     DOI: 10.1124/jpet.108.137992

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  58 in total

1.  COX1 and COX2 expression in non-neuronal cellular compartments of the rhesus macaque brain during lentiviral infection.

Authors:  Candan Depboylu; Eberhard Weihe; Lee E Eiden
Journal:  Neurobiol Dis       Date:  2011-01-08       Impact factor: 5.996

Review 2.  Bone marrow fat: linking adipocyte-induced inflammation with skeletal metastases.

Authors:  Aimalie L Hardaway; Mackenzie K Herroon; Erandi Rajagurubandara; Izabela Podgorski
Journal:  Cancer Metastasis Rev       Date:  2014-09       Impact factor: 9.264

3.  Aldose reductase inhibition prevents endotoxin-induced inflammatory responses in retinal microglia.

Authors:  Kun-Che Chang; Jessica Ponder; Daniel V Labarbera; J Mark Petrash
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-05-02       Impact factor: 4.799

4.  Cyclooxygenase-2 in newborn hyperoxic lung injury.

Authors:  Rodney D Britt; Markus Velten; Trent E Tipple; Leif D Nelin; Lynette K Rogers
Journal:  Free Radic Biol Med       Date:  2013-04-25       Impact factor: 7.376

5.  Inhibition of COX-2-mediated eicosanoid production plays a major role in the anti-inflammatory effects of the endocannabinoid N-docosahexaenoylethanolamine (DHEA) in macrophages.

Authors:  Jocelijn Meijerink; Mieke Poland; Michiel G J Balvers; Pierluigi Plastina; Carolien Lute; Jvalini Dwarkasing; Klaske van Norren; Renger F Witkamp
Journal:  Br J Pharmacol       Date:  2014-09-23       Impact factor: 8.739

6.  The role of cyclooxygenase-2 in mechanical ventilation-induced lung injury.

Authors:  Joshua A Robertson; David Sauer; Jeffrey A Gold; Stephanie A Nonas
Journal:  Am J Respir Cell Mol Biol       Date:  2012-05-03       Impact factor: 6.914

7.  Prostaglandins D2 and E2 have opposite effects on alveolar macrophages infected with Histoplasma capsulatum.

Authors:  Priscilla A T Pereira; Patrícia A Assis; Morgana K B Prado; Simone G Ramos; David M Aronoff; Francisco W G de Paula-Silva; Carlos A Sorgi; Lúcia H Faccioli
Journal:  J Lipid Res       Date:  2017-12-07       Impact factor: 5.922

8.  COX-2 inhibitor reduces skeletal muscle hypertrophy in mice.

Authors:  Margaret L Novak; William Billich; Sierra M Smith; Kunal B Sukhija; Thomas J McLoughlin; Troy A Hornberger; Timothy J Koh
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-01-28       Impact factor: 3.619

9.  Prostaglandin E2 Inhibits NLRP3 Inflammasome Activation through EP4 Receptor and Intracellular Cyclic AMP in Human Macrophages.

Authors:  Milena Sokolowska; Li-Yuan Chen; Yueqin Liu; Asuncion Martinez-Anton; Hai-Yan Qi; Carolea Logun; Sara Alsaaty; Yong Hwan Park; Daniel L Kastner; Jae Jin Chae; James H Shelhamer
Journal:  J Immunol       Date:  2015-04-27       Impact factor: 5.422

10.  Histone deacetylase inhibitor suberoylanilide hydroxamic acid attenuates Toll-like receptor 4 signaling in lipopolysaccharide-stimulated mouse macrophages.

Authors:  Wei Chong; Yongqing Li; Baoling Liu; Ting Zhao; Eugene Y Fukudome; Zhengcai Liu; William M Smith; George C Velmahos; Marc A deMoya; Hasan B Alam
Journal:  J Surg Res       Date:  2012-07-26       Impact factor: 2.192

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.